Coronary calcification measures predict mortality in symptomatic women and men.
CORONARY ARTERY DISEASE
Computed Tomography Angiography
Coronary Stenosis
Electronic Health Records
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
03
03
2022
accepted:
03
11
2022
entrez:
29
12
2022
pubmed:
30
12
2022
medline:
3
1
2023
Statut:
ppublish
Résumé
To assess the prognostic value of absolute and sex-specific, age-specific and race/ethnicity-specific (Multi-Ethnic Study of Atherosclerosis, MESA) percentiles of coronary artery calcification in symptomatic women and men. The study population consisted of 4985 symptomatic patients (2793 women, 56%) visiting a diagnostic outpatient cardiology clinic between 2009 and 2018 who were referred for cardiac CT to determine Coronary Artery Calcium Score (CACS). Regular care data were used and these data were linked to the databases of Statistics Netherlands for all-cause mortality data. Kaplan-Meier curves, multivariate Cox proportional hazards regression and concordance statistics were used to evaluate the prognostic value of CACS and MESA percentiles. Women were older compared with men (60 vs 59 years). Median CACS was 0 (IQR: 0-54) in women and 42 (IQR: 0-54) in men. After a median follow-up of 4.4 years (IQR: 3.1-6.3), 116 (2.3%; 53 women and 63 men) patients died. MESA percentiles did not perform better compared with absolute CACS (C-statistic 0.65, 95% CI 0.57 to 0.73, vs 0.66, 95% CI 0.58 to 0.74, in women and 0.59, 95% CI 0.51 to 0.67, vs 0.62, 95% CI 0.55 to 0.69, in men, for the percentiles and absolute CACS, respectively). In symptomatic individuals absolute CACS predicts mortality with a moderately good performance. MESA percentiles did not perform better compared with absolute CACS, thus there is no need to use them. Including degree of stenosis in the model might slightly improve mortality risk prediction in women, but not in men.
Identifiants
pubmed: 36581377
pii: openhrt-2022-002005
doi: 10.1136/openhrt-2022-002005
pmc: PMC9806039
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: LH, IIT and GAS are employed by Cardiology Centers of the Netherlands. All other authors declare no competing interests.
Références
Eur Heart J Cardiovasc Imaging. 2017 May 01;18(8):922-929
pubmed: 28379388
J Am Coll Cardiol. 2007 Sep 4;50(10):953-60
pubmed: 17765122
Atherosclerosis. 2016 Sep;252:32-39
pubmed: 27494449
JACC Cardiovasc Imaging. 2020 Jul;13(7):1534-1545
pubmed: 31734213
Mayo Clin Proc. 1999 Mar;74(3):243-52
pubmed: 10089993
Am J Cardiol. 2001 Jun 15;87(12):1335-9
pubmed: 11397349
Eur Radiol. 2018 Apr;28(4):1365-1372
pubmed: 29116390
J Am Coll Cardiol. 2008 Jul 1;52(1):17-23
pubmed: 18582630
BMC Cardiovasc Disord. 2021 Jun 10;21(1):287
pubmed: 34112101
Eur Heart J Cardiovasc Imaging. 2016 Nov;17(11):1305-1314
pubmed: 26705490
Am J Med. 2021 Mar;134(3):341-350.e1
pubmed: 32822664
J Womens Health (Larchmt). 2004 Apr;13(3):273-83
pubmed: 15130256
Neth Heart J. 2019 May;27(5):272-280
pubmed: 30734147
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
J Am Coll Cardiol. 2009 Jan 27;53(4):345-52
pubmed: 19161884
Circulation. 2005 Mar 15;111(10):1313-20
pubmed: 15769774
Am J Cardiol. 2007 Aug 1;100(3):409-14
pubmed: 17659919
Circulation. 2020 Sep 8;142(10):917-919
pubmed: 32897743
Eur Heart J. 2018 Nov 1;39(41):3727-3735
pubmed: 30212857
Am J Cardiol. 2016 Dec 1;118(11):1611-1615
pubmed: 27717443
Circulation. 2006 Jan 3;113(1):30-7
pubmed: 16365194
Am J Cardiol. 2021 Jun 15;149:16-20
pubmed: 33757786
JACC Cardiovasc Imaging. 2021 Sep;14(9):1804-1814
pubmed: 33865779
Circ Cardiovasc Imaging. 2016 Apr;9(4):e003742
pubmed: 27072301